GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends
📈
AI Sentiment
Highly Positive
8/10
- Home
- XOMAO
XOMAO
AGNC Investment Corp.
as of 12-26-2025 2:43pm EST
$25.51
$0.02
-0.07%
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
| Founded: | N/A | Country: | United States |
| Employees: | 13 | City: | EMERYVILLE |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest AGNC Investment Corp. News
XOMAO Breaking Stock News: Dive into XOMAO Ticker-Specific Updates for Smart Investing
Simply Wall St.
XOMA Royalty (NASDAQ:XOMA) shareholders have earned a 13% CAGR over the last three years
âž–
AI Sentiment
Neutral
4/10
Compare XOMAO vs Leading Stocks
See how XOMAO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "XOMAO AGNC Investment Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.